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Biogenic gold (Au) and silver (Ag) nanoparticles were synthesized using seaweed Sargassum wightii (Sw) and their 
antiviral activity against Herpes Simplex Virus (HSV-1 and HSV-2) was evaluated. Efficacy of Sw-Au and Sw-Ag 
nanoparticles against HSV was estimated by the reduction of cytopathic effect (CPE) caused by HSV, which was observed 
in a dose-dependent manner. Sw-Au nanoparticles reduced 70% CPE of HSV-1 and HSV-2 at 10 μL and 25 μL, 
respectively, whereas 2.5 μL Sw-Ag nanoparticles effectively reduced 70% CPE of HSV-1 and HSV-2. Cytotoxicity was 
estimated in Vero cells by MTT assay. Sw-Au nanoparticles were significantly non-toxic in all the concentrations tested, 
whereas Sw-Ag nanoparticles were found to be toxic in higher concentrations. Sw-Au nanoparticles showed cell viability of 
93.12-85.18 % in the range of 2.5-25 µL, and Sw-Ag nanoparticles showed cell viability of 97.21-21.91% in the range of  
1-10 μL. Sw-Au and Sw-Ag nanoparticles effectively reduce the CPE caused by both HSV-1 and HSV-2 in Vero cells and 
can be used to treat HSV infections.  
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Introduction 
Recently, the application of nanoparticles has 
advanced in therapeutics1, targeted drug delivery2,3, 
bio-imaging4,5, biosensors6, fluorescent biological 
labels7,8, gene delivery9,10, tissue engineering11,12, 
separation and purification of biological molecules 
and cells13, detection of pathogens and proteins14,15. 
Au and Ag nanoparticles have gained considerable 
attention in the field of bio-molecular sensing, rapid 
pathogen detection, targeted drug delivery and 
nanoparticle-based cancer therapy owing to their 
unique physical and chemical properties16. Important 
biological entities, such as DNA, proteins, antigens, 
and antibodies which have nanometer-size 
dimensions, may serve as good candidate targets for 
interactions with such nanoparticles. Viruses are 
nano-sized pathogens that can infect and cause 
various diseases in humans, animals, and plants.  
Development of new antiviral drugs that will help 
target the virus though maintaining host cell viability 
is challenging17,18. Generation of materials with 
different nanoscales and shapes by utilizing the 
physico-chemical properties and technological 
advances available could substantiate the biological 
applications of nanomaterials18. Over the last century, 
metal nanoparticles have attracted researchers to 
explore their applications in biomedical sciences19. 
Silver and gold nanoparticles have proved to be 
potent antiviral agents against human parainfluenza 
virus20, H7N3 influenza Avirus21, human norovirus22, 
HIV23, poliovirus24, HSV25, and hepatitis C virus26.  
Herpes Simplex Viruses (HSV-1 and HSV-2) are 
ubiquitous human pathogens of the 
alphaherpesviruses family20. HSV causes herpes 
labialis, pharyngitis, herpetic gingivostomatitis, 
herpes genitalis, keratitis, encephalitis, and neonatal 
herpes infection27. After primary infection, the virus 
establishes latent infection in sensory and autonomic 
neural ganglia which persists for lifetime. HSV can 
result in physical disability, social exclusion, and 
psychological distress, and can cause even life-
threatening infections in newborns and immune 
compromised individuals28. According to the World 
Health Organization (WHO) report in 2012, globally 
3.7 billion and 417 million people have been infected 
with HSV-1 and HSV-2, respectively29. 
Acyclovir (ACV), penciclovir (PCV), and their 
pro-drugs are currently being used for treating HSV 
infections and reactivation30. Development of drug 
resistance among high-risk groups such as immuno-




compromised and transplantation patients, prompted 
the search of alternative therapeutic agents with a 
different mechanism of action28. Use of nanomaterials 
in interactions of biological targets (particularly 
microbes) has gained much attention. The rich 
diversity of brown seaweeds belonging to the 
genus Sargassum species is an untapped reservoir of 
their various biological activities31. In the present 
study, an attempt has been made to evaluate the anti-
HSV potential of gold and silver nanoparticles 
synthesized by Sargassum withtii.  
 
Materials and Methods 
 
Collection of marine alga and nanoparticle synthesis  
Marine brown alga S. wightii Greville was 
collected from Mandapam camp, Rameshwaram, 
Tamil Nadu, India, during April 2016. The collected 
algal samples were washed with deionized water to 
remove other debris and shade-dried. Dried algal 
samples were powdered using an electronic blender. 
Sw-Au and Sw-Ag nanoparticles were synthesized  
as reported earlier32,33 (Fig. 1). Briefly, for Au 
nanoparticles, 1 g of seaweed powder was soaked in 
10 mL 10-3M concentration of chloroauric acid 
(HAuCl4) solution for 12 h at stirring condition. After 
12 h, the color turned into transparent ruby red, which 
indicates the formation of Au nanoparticles. For Ag 
nanoparticles, 1 g of seaweed powder was soaked in 
100 mL double distilled water for 24 h and filtered 
using Whatman no.1 filter paper. The filtrates (10 
mL) react with 90 mL of 10-3 M silver nitrate solution 
for 15 h under stirring condition. After 15 h, the color 
turned to dark brown which indicated the formation of 
Ag nanoparticles.  
Cells and viruses 
Vero cells were procured from the National Centre 
for Cell Science (NCCS), Pune, India and maintained 
in minimal essential medium (MEM, Sigma) 
supplemented with 10% fetal bovine serum (FBS) and 
1% antibiotic solution (penicillin and streptomycin). 
Cells were then grown in T25 tissue culture flask and 
after reaching 70-80% confluence, the cells were 
infected with stock HSV and incubated for three days. 
After observing 100% cytopathic effect (CPE), the 
flask was freeze-thawed repeatedly. The content was 
transferred to a new 15 mL tube and centrifuged  
for 10 min. The viral suspension containing the 
supernatant was aliquoted into sterile screw-capped 
cryovials and stored at -80 oC until use. The 
infectivity of the viruses was estimated by following 
the Spearman and Karber method34,35.  
 
Cytotoxic assay 
Cytotoxic activity of Sw-Au and Sw-Ag 
nanoparticles was estimated using Vero cells as 
described by Mosmann et al.36 Briefly, 5×104 
cells/well were seeded in 96 well tissue culture plates 
and incubated for 24 h at 37 °C with 5% CO2. After 
24 h, the complete medium was removed and the cells 
were treated with varying concentrations of Sw-Au 
and Sw-Ag nanoparticles in triplicate and the plates 
were incubated for 48 h. After incubation, the medium 
was removed and 100 µL of MTT reagent (MTT (3-
(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium 
bromide) was added and the plates were incubated 
again at 37 °C for 4 h. After incubation, the MTT was 
completely removed, 100 µL of dimethyl sulfoxide 
(DMSO) was added, the plates were gently shaken 




Fig. 1 — Schematic representation of gold and silver nanoparticles using seaweed Sargassum wightii 




reader (BioTek, USA). The percentage cell viability 
was calculated using the following formula: 
 
         OD of the sample  
% Cell viability = ---------------------- × 100 
         OD of the control  
 
Anti HSV activity determination by CPE reduction method 
An antiviral assay was performed as described by 
Tang et al.37, with some modifications. Briefly, 96 well 
plates were seeded with Vero cells at a density of 
5×104 cells/well. After reaching 80% confluence, the 
medium was removed and 100µL of 107.5 TCID50/mL 
virus particles of HSV-1 and 106.5 TCID50/mL HSV-2 
particles were added and incubated for 1 h for viral 
adsorption. Unadsorbed viral particles were removed 
by washing the cell monolayer with serum-free 
medium. The cells were treated with different 
concentrations of Sw-Au (2.5, 5, 10 and 25 μL) and 
Sw-Ag (0.5, 1, 2.5 and 5 μL) nanoparticles. Cells 
treated with ACV (100 μg/mL) served as drug control, 
cells infected with virus alone served as virus control 
and Vero cells alone served as cell control. Then, the 
plates were incubated for three days at 37 ºC in 5% 
CO2. The plates were examined microscopically for 
CPE every day. Anti-viral activity of Sw-Au and Sw-
Ag nanoparticles was assessed using the grading 
system described by Kudi et al.38 The degree of CPE 
inhibition upon treatment was marked as follows: 
'++++' total inhibition, '+++’ 75% inhibition, '++' 50% 
inhibition, and 'Nil' as no inhibition.  
 
Results and Discussion  
The pharmaceutical potential of marine algae 
(seaweeds) has been recognized for several years. 
Seaweeds contain various biologically active 
substances such as polysaccharides and phenolic 
compounds with well-recognized biological and 
pharmacological potential in therapeutic applications 
for human diseases39,40. Several physical and chemical 
protocols for synthesis of metallic nanoparticles are 
followed by the material scientists currently. In earlier 
studies, synthesis of gold, silver and palladium 
nanoparticles using seaweed Sargassum species, such 
as S. myriocystum,41 S. swartzii,42 S. polycystum,43 S. 
plagiophyllum,44 and S. wightii45 has been 
successfully carried out. The application of 
functionalized nanomaterials in biomedical fields in 
recent years is derived from physical and chemical 
properties of nanomaterials with the combination of 
surface-bound ligands (natural or synthetic). As 
surface-bound ligands, these biomolecules or their 
synthetic analogues are spatially directed and  
render their carrier nanomaterials into multivalent 
biologically effective compounds. Bio-functionalization 
of nanomaterials can be extended to the development 
of antivirals that act by interfering with viral 
infections, particularly during entry and attachment.  
Cytotoxicity analysis of Sw-Au nanoparticles at 
2.5, 5, 10 and 25 µL showed 93.12 %, 88.40 %, 85.40 
% and 85.18 % cell viability, respectively (Table 1). 
Sw-Ag nanoparticles at 5 and 10 μL showed toxicity 
but the lower concentrations, i.e., 1 and 2.5 μL tested 
were non-toxic and showed 97.21 % and 84.58 % cell 
viability, respectively (Table 1). Sw-Au nanoparticles 
were found to be non-toxic to Vero cells at the four 
different concentrations tested. 
The antiviral efficacy of Sw-Au and Sw-Ag 
nanoparticles against HSV was estimated by the 
reduction of CPE caused by the virus. Sw-Au 
nanoparticles (2.5, 5, 10 and 25 μL) and Sw-Ag 
nanoparticles (0.5, 1, 2.5 and 5 μL) were tested for 
anti-HSV activity; both Sw-Au and Sw-Ag 
nanoparticles (Figs. 2&3) effectively reduced CPEs 
caused by HSV. Reduction of CPE was observed in a 
dose-dependent manner. Sw-Au nanoparticles reduced 
70% CPE of HSV-1 and HSV-2 at 10 and 25 μL, 
whereas at 1 μL Sw-Ag nanoparticles effectively 
reduced 70% and 50% CPE of HSV-1 and HSV-2, 
respectively (Table 1). About 2.5 μL was found to 
reduce 70% CPE for both HSV-1 and HSV-2. Sw-Ag 
nanoparticles at 5 μL had better anti-viral activity but 
morphological changes were observed in Vero cells 
owing to toxicity (Table 2).  
Bio-functionalization of nanoparticles enables 
higher dose drug delivery to target cells or tissue46. 
Hence, in the present study, Au and Ag nanoparticles 
were functionalized with S. wightii extract and tested 
against HSV. It was observed that 10 and 25 μL Sw-
Au nanoparticles reduced 70% CPE of HSV-1 and 
HSV-2, whereas 2.5 μL of Sw-Ag nanoparticles 
reduced 70% CPE of both HSV-1 and HSV-2. Also, 
all these concentrations were non-toxic to Vero cells.  
 
Table 1 — Dose-dependent cytotoxicity of Ag and Au 









1 97.21 ± 0.74 2.5 93.12 ± 1.79 
2.5  84.58 ± 1.17 5 88.40 ± 1.67 
5 43.50 ± 0.63 10 85.40 ± 1.77 
10  21.91 ± 0.28 25 85.18 ± 1.54 
Control 100 ± 0.00 Control 100  ± 0.00 
 





Mercapto-ethanesulfonate capped silver47 and gold48 
nanoparticles inhibit HSV activity and their ability to 
mimic cell surface receptor heparin sulphate. Size-
dependant tannic acid-modified silver nanoparticles 
(13 nm, 33 nm and 46 nm) are capable of reducing 
HSV-2 infectivity both in vitro and in vivo49. Through 
the literature, it is inferred that functionalized gold 
and silver nanoparticles possess size-dependent 
interaction and the ability to block virus attachment 
and entry, and this is responsible for the observed 
antiviral activity.  
 
Conclusion 
The study revealed that Sw-Au and Sw-Ag 
nanoparticles inhibit HSV-1 and HSV-2 infection to 
 
 
Fig. 3 — Photographs exhibiting anti-HSV 1 and 2 activity of Sw-
Ag nanoparticles: (a & b) virus control; (c and d) ACV drug 
treated (positive control); (e and f) 0.5 µL; g and h) 1 µL; (i and j) 




Fig. 2 — Photographs exhibiting anti-HSV 1 and 2 activity of 
Sw-Au nanoparticles: (a and b) virus control; (c and d) ACV drug 
treated (positive control); (e and f) 2.5 µL; g and h) 5 µL; (i and j) 
10 µL; and (k and l) 25 µL of Sw-Au nanoparticles treated 
 
Table 2 — Anti-HSV 1 and 2 action of Sw-Au and Sw-Ag 
nanoparticles at different concentrations 
Conc. of nanoparticles (μL) Viruses 
HSV-1 HSV-2 
Sw-Au nanoparticles 
2.5 Nil Nil 
5 ++ ++ 
10 +++ +++ 
25 +++ +++ 
Sw-Ag nanoparticles 
0.5 ++ ++ 
1 +++ ++ 
2.5 +++ +++ 
5 +++ +++ 
Acyclovir (100 μg/mL) ++++ ++++ 
Nil, no inhibition; ++, 50 % inhibition; +++ , 70% inhibition;
++++ , 100% inhibition 
 




Vero cells in a dose-dependent manner. The dose 
response inhibition showed that Sw-Au nanoparticles 
reduced 70% CPE of HSV-1 and HSV-2 at 10 and 25 
μL, respectively. Sw-Ag nanoparticles effectively 
reduced 70% CPE of both HSV-1 and HSV-2 at 2.5 
μL. Cytotoxicity analysis revealed that Sw-Au 
nanoparticles were significantly non-toxic in higher 
concentration of 25 μL tested and showed 85.18% of 
cell viability. Sw-Ag nanoparticles were found to be 
toxic in higher concentrations; up to 2.5 μL it was 
nontoxic and showed 84.58% cell viability. On the 
basis of these observations, this study concludes that 
bio-based preparation of metal nanoparticles could be 
used as novel antiviral agents.  
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